CASI Pharmaceuticals Jumps 24% After Hours Despite Nasdaq Delisting
CASI shares rose over 24% in after-hours trading even as the company faces Nasdaq delisting and plans to shift trading to OTC Markets.
- Beyond The Veil Editorial
- Published
- 6 min read
- New York, United States
Illustration generated for this decode. It is not a photograph of the event.
Event chart
- Chart time
- · 03:02 EST local · Cast for the report's publication time
- Chart location
- New York, United States (40.71°N, 74.01°W)
Tropical zodiac · Placidus houses · mean lunar nodes · Waxing Gibbous
Tightest aspects
- Moon quincunx Plutoorb 0.17°
- Saturn conjunct Neptuneorb 0.48°
- Mars square Uranusorb 0.87°
- Mercury conjunct Venusorb 2.41°
- Saturn sextile Plutoorb 3.03°
Placements
- Sun7°56′ Pis
- Moon4°38′ Can
- Mercury22°33′ Pis R
- Venus20°09′ Pis
- Mars26°48′ Aqu
- Jupiter15°20′ Can R
- Saturn1°25′ Ari
- Uranus27°40′ Tau
- Neptune0°57′ Ari
- Pluto4°27′ Aqu
- Cast for the moment the source report was published, not a verified time of the event itself.
CASI Pharmaceuticals (NASDAQ: CASI) ripped more than 24% higher in after-hours trading—up to roughly $0.28—at the exact moment the company is staring down a formal Nasdaq delisting and signaling a move to OTC Markets. That’s not the “normal” script: delisting headlines typically crush liquidity expectations, not ignite a bid.
This kind of upside glitch is where mundane astrology gets useful: when the sky says “re-price it now” even while the fundamentals scream “structural damage.”
Veil Glimpse: When a market surges on bad news, you’re watching positioning and narrative control fight for dominance in real time.
Read with an account
Start free, or subscribe for full premium decodes, the archive, and the Veil Agent.